Identification of a Bromodomain-like Region in 15-Lipoxygenase-1 Explains Its Nuclear Localization.

activity-based probes bromodomains inhibitors lipoxygenases oxidoreductases

Journal

Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543

Informations de publication

Date de publication:
27 09 2021
Historique:
received: 25 05 2021
pubmed: 14 8 2021
medline: 17 11 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

Lipoxygenase (LOX) activity provides oxidative lipid metabolites, which are involved in inflammatory disorders and tumorigenesis. Activity-based probes to detect the activity of LOX enzymes in their cellular context provide opportunities to explore LOX biology and LOX inhibition. Here, we developed Labelox B as a potent covalent LOX inhibitor for one-step activity-based labeling of proteins with LOX activity. Labelox B was used to establish an ELISA-based assay for affinity capture and antibody-based detection of specific LOX isoenzymes. Moreover, Labelox B enabled efficient activity-based labeling of endogenous LOXs in living cells. LOX proved to localize in the nucleus, which was rationalized by identification of a functional bromodomain-like consensus motif in 15-LOX-1. This indicates that 15-LOX-1 is not only involved in oxidative lipid metabolism, but also in chromatin binding, which suggests a potential role in chromatin modifications.

Identifiants

pubmed: 34388301
doi: 10.1002/anie.202106968
pmc: PMC8518382
doi:

Substances chimiques

Enzyme Inhibitors 0
Arachidonate 15-Lipoxygenase EC 1.13.11.33

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21875-21883

Informations de copyright

© 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Références

Structure. 2015 Jan 6;23(1):80-92
pubmed: 25533489
Bioorg Med Chem. 2006 Jun 15;14(12):4295-301
pubmed: 16500106
J Ethnopharmacol. 2018 May 10;217:205-211
pubmed: 29474901
PeerJ. 2014 Jun 10;2:e414
pubmed: 24949235
J Biol Chem. 2010 Mar 5;285(10):7610-8
pubmed: 20048151
Bioorg Med Chem. 2019 Sep 1;27(17):3745-3759
pubmed: 31331653
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13182-7
pubmed: 9789062
Br J Pharmacol. 2010 Oct;161(3):555-70
pubmed: 20880396
Oncogene. 2007 Aug 13;26(37):5521-7
pubmed: 17694091
J Med Chem. 2020 Jun 11;63(11):5625-5663
pubmed: 32031378
Prog Lipid Res. 2006 Jul;45(4):334-56
pubmed: 16678271
Am J Physiol Heart Circ Physiol. 2002 Mar;282(3):H999-H1006
pubmed: 11834498
Atherosclerosis. 1998 Feb;136(2):203-16
pubmed: 9543090
Int J Cancer. 2000 Jul 1;87(1):37-43
pubmed: 10861450
Nat Struct Biol. 1999 Jul;6(7):601-4
pubmed: 10404206
FEBS J. 2017 Oct;284(20):3422-3436
pubmed: 28815970
Nat Chem Biol. 2019 Dec;15(12):1137-1147
pubmed: 31740834
Neuroscience. 2007 Dec 12;150(3):585-91
pubmed: 17942241
Anticancer Res. 2000 Sep-Oct;20(5A):2861-5
pubmed: 11062694
Redox Biol. 2015 Dec;6:297-310
pubmed: 26298204
J Exp Med. 1993 Dec 1;178(6):1935-46
pubmed: 8245774
Nat Methods. 2007 Oct;4(10):822-7
pubmed: 17901872
J Biol Chem. 1999 Sep 3;274(36):25594-8
pubmed: 10464294
PLoS One. 2018 Aug 17;13(8):e0202424
pubmed: 30118527
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12165-70
pubmed: 14530386
Nat Biotechnol. 2009 Apr;27(4):387-94
pubmed: 19329999
Biochem Pharmacol. 2017 Sep 15;140:41-52
pubmed: 28595877
Chem Rev. 2011 Oct 12;111(10):5866-98
pubmed: 21936577
Chembiochem. 2016 Sep 2;17(17):1598-601
pubmed: 27271974
Angew Chem Int Ed Engl. 2016 Sep 26;55(40):12488-93
pubmed: 27600208
Front Cell Dev Biol. 2020 Jul 15;8:594
pubmed: 32760721
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E4966-75
pubmed: 27506793
Mol Biosyst. 2011 Oct;7(10):2899-908
pubmed: 21804994
Biochem Biophys Res Commun. 2020 May 14;525(4):909-914
pubmed: 32171526
J Plant Physiol. 2006 Feb;163(3):348-57
pubmed: 16386332
Chembiochem. 2021 Feb 15;22(4):630-638
pubmed: 32881211
J Biol Chem. 2002 Oct 11;277(41):38550-6
pubmed: 12140292
J Biol Chem. 2003 Mar 21;278(12):10257-63
pubmed: 12525477
Angew Chem Int Ed Engl. 2012 Jul 9;51(28):7035-40
pubmed: 22689512
Prostaglandins Other Lipid Mediat. 2000 Aug;62(3):255-70
pubmed: 10963793
J Cancer Res Clin Oncol. 2019 Aug;145(8):2083-2095
pubmed: 31203442
Biomed Pharmacother. 2020 Sep;129:110354
pubmed: 32540644
Biochim Biophys Acta. 2015 Apr;1851(4):308-30
pubmed: 25316652
Angew Chem Int Ed Engl. 2016 Sep 26;55(40):12300-5
pubmed: 27612308
Nature. 2009 Oct 1;461(7264):664-8
pubmed: 19794495
Structure. 2008 Apr;16(4):643-52
pubmed: 18400184
Angew Chem Int Ed Engl. 2021 Sep 27;60(40):21875-21883
pubmed: 34388301
Curr Opin Chem Biol. 2004 Feb;8(1):54-9
pubmed: 15036157

Auteurs

Deng Chen (D)

Department Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, The Netherlands.

Zhangping Xiao (Z)

Department Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, The Netherlands.

Hao Guo (H)

Department Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, The Netherlands.

Dea Gogishvili (D)

Department Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, The Netherlands.

Rita Setroikromo (R)

Department Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, The Netherlands.

Petra E van der Wouden (PE)

Department Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, The Netherlands.

Frank J Dekker (FJ)

Department Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH